Cancer, Advanced Active Not Recruiting Phase 1 Trials for Erlotinib (DB00530)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00543504Bevacizumab in Multiple Phase I CombinationsTreatment
NCT01197170Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceTreatment